Publicaciones (362) Publicaciones de JORGE MATÍAS-GUIU GUÍA

2024

  1. A data-driven approach to complement the A/T/(N) classification system using CSF biomarkers

    CNS Neuroscience and Therapeutics, Vol. 30, Núm. 2

  2. Leptin haploinsufficiency exerts sex-dependent partial protection in SOD1G93A mice by reducing inflammatory pathways in the adipose tissue

    Scientific Reports, Vol. 14, Núm. 1

  3. Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landscape and Opportunities

    Biomolecules, Vol. 14, Núm. 1

  4. Murine experimental models of amyotrophic lateral sclerosis: An update

    Neurologia, Vol. 39, Núm. 3, pp. 282-291

2023

  1. A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS)

    Multiple Sclerosis Journal, Vol. 29, Núm. 4-5, pp. 615-627

  2. A review of novel Cognitive Challenge Tests for the assessment of preclinical Alzheimer's disease

    Neuropsychology, Vol. 37, Núm. 6, pp. 661-672

  3. A taxonomic approach to cognitive diagnostics is viable and achievable in MS

    Multiple Sclerosis Journal

  4. Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study

    Multiple Sclerosis Journal, Vol. 29, Núm. 11-12, pp. 1393-1405

  5. Are there cognitive and neuroimaging signatures in long COVID?

    Brain Communications

  6. Artificial intelligence in cognitive impairment and dementias

    Kranion, Vol. 18, Núm. 2, pp. 52-56

  7. Bilingual Primary Progressive Aphasia: A Scoping Review of Assessment and Treatment Practices

    Journal of Alzheimer's Disease, Vol. 96, Núm. 4, pp. 1453-1476

  8. Cognitive dysfunction in patients with primary adrenal insufficiency: A systematic review

    Applied Neuropsychology:Adult, Vol. 30, Núm. 6, pp. 802-813

  9. Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study)

    European heart journal, Vol. 44, Núm. 2, pp. 113-125

  10. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach

    Psychiatry Research, Vol. 319

  11. Emotional processing in patients with single brain damage in the right hemisphere

    BMC Psychology, Vol. 11, Núm. 1

  12. FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration

    Frontiers in Psychology, Vol. 14

  13. Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research

    Alzheimer's and Dementia, Vol. 19, Núm. 12, pp. 5817-5836

  14. In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies

    Cells, Vol. 12, Núm. 11

  15. Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis

    Journal of Alzheimer's disease : JAD, Vol. 91, Núm. 2, pp. 705-717

  16. Multimodal neuroimaging in post-COVID syndrome and correlation with cognition

    Brain : a journal of neurology, Vol. 146, Núm. 5, pp. 2142-2152